| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 1991 | 13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma | Chow J.M.; ANN-LII CHENG ; Su I.J.; Wang C.H. | Cancer | 22 | | |
| 2013 | Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma | Ying-Chun Shen ; DA-LIANG OU ; CHIUN HSU ; Lin K.-L.; Chang C.-Y.; CHING-YU LIN ; Liu S.-H.; ANN-LII CHENG | British Journal of Cancer | 146 | 140 | |
| 2011 | Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells | Chen K.-F.; Chen H.-L.; Tai W.-T.; Feng W.-C.; CHIH-HUNG HSU ; PEI-JER CHEN ; ANN-LII CHENG | Journal of Pharmacology and Experimental Therapeutics | 253 | 247 | |
| 1994 | Acute confusion induced by a high-dose infusion of 5-fluorouracil and folinic acid | KUN-HUEI YEH ; ANN-LII CHENG | Journal of the Formosan Medical Association | 16 | 0 | |
| 2008 | Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma | CHIA-CHI LIN ; YEONG-SHIAU PU ; CHIH-HUNG HSU ; Keng H.-Y.; ANN-LII CHENG ; CHIH-HSIN YANG | Urologic Oncology: Seminars and Original Investigations | 8 | 7 | |
| 2014 | Adaptation of international guidelines for metastatic colorectal cancer: An Asian consensus | ANN-LII CHENG ; Li J.; Vaid A.K.; Ma B.B.Y.; Teh C.; Ahn J.B.; Bello M.; Charoentum C.; Chen L.-T.; De Lima Lopes G.; Jr.; Ho G.F.; Kong H.L.; Lam K.O.; Liu T.S.; Park Y.S.; Sriuranpong V.; Sudoyo A.W.; Wang J.-Y.; Zhang J.; Zhang S.Z.; Ciardiello F.; Köhne C.-H.; Shaw M.; Kim T.W. | Clinical Colorectal Cancer | 16 | 15 | |
| 2018 | Adiposity, inflammation, and breast cancer pathogenesis in Asian Women | Iyengar N.M.; I-CHUN CHEN ; Zhou X.K.; Giri D.D.; Falcone D.J.; Winston L.A.; Wang H.; Williams S.; YEN-SHEN LU ; Hsueh T.-H.; ANN-LII CHENG ; Hudis C.A.; CHING-HUNG LIN ; Dannenberg A.J. | Cancer Prevention Research | 31 | 29 | |
| 2010 | Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach | Ying-Chun Shen ; CHIUN HSU ; Chen L.-T.; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG | Journal of Hepatology | 118 | 112 | |
| 1986 | Adult acute lymphoblastic leukemia--lineage specific classification of 30 cases. | ANN-LII CHENG ; YAO-CHANG CHEN ; Wang C.H.; MING-CHING SHEN ; Hsieh R.P.; HWEI-FANG TIEN ; Liu M.C.; HONG-SHIEE LAI ; Liu C.H. | Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association | 0 | 0 | |
| 1989 | Adult non-Hodgkin's lymphoma in Taiwan area: A clinicopathologic study of 123 cases based on working formulation classification | ANN-LII CHENG ; YAO-CHANG CHEN ; Su I.-J.; Wang C.-H.; Hsieh H.-C.; Chen C.-L.; HONG-SHIEE LAI ; Liu T.-W.; HWEI-FANG TIEN ; MING-CHING SHEN ; Liu C.-H. | Journal of the Formosan Medical Association | 12 | 0 | |
| 1991 | Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis | Su I.-J.; Hsieh H.-C.; KAI-HSIN LIN ; Uen W.-C.; CHUAN-LIANG KAO ; Chen C.-J.; ANN-LII CHENG ; Kadin M.E.; Chen J.-Y. | Blood | 243 | 270 | |
| 2014 | The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells | Lin Y.-H.; Chen B.Y.-H.; Lai W.-T.; Wu S.-F.; JIH-HWA GUH ; ANN-LII CHENG ; LIH-CHING HSU | Naunyn-Schmiedeberg's Archives of Pharmacology | 34 | 32 | |
| 2021 | ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240 | Vogel, Arndt; Merle, Philippe; Verslype, Chris; Finn, Richard S; Zhu, Andrew X; ANN-LII CHENG ; Chan, Stephen Lam; Yau, Thomas; Ryoo, Baek-Yeol; Knox, Jennifer; Daniele, Bruno; Qin, Shukui; Wei, Ziwen; Miteva, Yanna; Malhotra, Usha; Siegel, Abby B; Kudo, Masatoshi | Therapeutic advances in medical oncology | 6 | 5 | |
| 1987 | Allogeneic bone marrow transplantation in the treatment of leukemia--a preliminary report | YAO-CHANG CHEN ; Wang C.H.; Lin D.T.; Lui P.T.; ANN-LII CHENG ; Liu T.W.; Tsay W.; HWEI-FANG TIEN ; Liu M.C.; Chuu W.M. | Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association | 0 | 0 | |
| 1994 | An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin [2] | KUN-HUEI YEH ; ANN-LII CHENG | Journal of Clinical Oncology | 18 | 16 | |
| 1997 | Angioimmunoblastic lymphadenopathy with dysproteinemia - lack of a prognostic value of clear cell morphology | Ch’ang H.-J.; Su I.J.; Chen C.L.; Zmija I.P.; YAO-CHANG CHEN ; Wang C.H.; ANN-LII CHENG | Oncology (Switzerland) | 7 | 7 | |
| 2021 | Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients | I-CHUN CHEN ; Hu, Fu-Chang; CHING-HUNG LIN ; Huang, Shu-Min; DWANG-YING CHANG ; ANN-LII CHENG ; YEN-SHEN LU | Breast (Edinburgh, Scotland) | 1 | 1 | |
| 2011 | Antiangiogenic strategies for the treatment of hepatocellular carcinoma | CHIUN HSU ; Ying-Chun Shen ; ANN-LII CHENG | Targeted Therapies for Hepatocellular Carcinoma | 0 | 0 | |
| 2021 | APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | Lau G.; Yu M.-L.; Wong G.; Thompson A.; Ghazinian H.; Hou J.-L.; Piratvisuth T.; Jia J.-D.; Mizokami M.; Cheng G.; Chen G.-F.; Liu Z.-W.; Baatarkhuu O.; ANN-LII CHENG ; Ng W.L.; Lau P.; Mok T.; Chang J.-M.; Hamid S.; Dokmeci A.K.; Gani R.A.; Payawal D.A.; Chow P.; Park J.-W.; Strasser S.I.; Mohamed R.; Win K.M.; Tawesak T.; Sarin S.K.; Omata M. | Hepatology International | 31 | 30 | |
| 2019 | The APPLE association president's message | ANN-LII CHENG | Liver Cancer | 0 | 0 | |
